Parkin, DM, Pisani, P, Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993: 54: 594–606.
Dunn, JE. Breast cancer among American Japanese in the San Francisco Bay area. Natl Cancer Inst Monogr
1977; 47: 157–60.
Trichopoulos, D, Yen, S, Brown, J, Cole, P, MacMahon, B. The effect of Westernization on urine estrogens, frequency of ovulation, and breast cancer risk. (A study of ethnic Chinese in the Orient and the USA.) Cancer 1984; 53: 187–92.
Kato, I, Tominaga, S, Kuroishi, T. Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Gann 1987; 78: 349–57.
Bjarnason, O, Day, NE, Snaedal, G, Tulinius, H. The effect of year of birth on the breast cancer age curve in Iceland. Int J Cancer 1974; 13: 689–96.
Wakai, K, Suzuki, S, Ohno, Y, Kawamura, T, Tamakoshi, A, Aoki, R. Epidemiology of breast cancer in Japan. Int J Epidemiol 1995; 24: 285–91.
Armstrong, B, Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617–31.
Hems, G. The contributions of diet and childbearing to breast-cancer rates. Br J Cancer 1978; 37: 974–82.
Eveleth, PB, Tanner, JM. Worldwide Variation In Human Growth. Cambridge, UK: Cambridge University Press, 1976.
Micozzi, MS. Nutrition, body size, and breast cancer. Yearbook Phys Anthropol 1985; 28: 175–206.
Albanes, D, Taylor, P. International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer 1990; 14: 69–77.
Tarone, RE, Chu, KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. JNCI 1992; 84: 1402–10.
Frisch, RE, Wyshak, G, Albright, NL, et al. Lower lifetime occurrence of breast cancer and cancers of the reproductive system among former college athletes. Am J Clin Nutr 1987; 45: 328–35.
Bernstein, L, Henderson, BE, Hanish, R, Sullivan-Halley, J, Ross, RK. Physical exercise and reduced breast cancer risk in young women. JNCI 1994; 86: 1403–8.
Mittendorf, R, Longnecker, MP, Newcomer, PA, et al. Strenuous physical activity in young adulthood and risk of breast cancer (United States). Cancer Causes Control 1995; 6: 347–53.
Welsh, cW. Dietary fat, calories, and mammary gland tumorigenesis. In: Jacobs, MM, ed. Exercise, Calories, Fat and Cancer. New York, NY (USA): Plenum Press 1992: 203–22.
Kelsey, JL, Gammon, MD, John, EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36–47.
Hunter, DJ, Willett, WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110–32.
Folsom, AR, Kaye, SA, Prineas, RJ, Potter, JD, Gapstur, SM, Wallace, RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131: 794–803.
Bruning, PF, Bonfrèr, JMG, Hart, AAM, et al. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992; 51: 14–9.
Schapira, DV, Kumar, NB, Lyman, GH, Cox, CE. Abdominal obesity and breast cancer risk. Ann Intern Med 1990; 112: 182–6.
Sellers, TA, Kushi, LH, Potter, JD, et al. Effect of family history, body fat distribution and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992; 326: 1323–9.
den Tonkelaar, I, Seidell, JC, Collette, H. Body fat distribution in relation to breast cancer in women participating in the DOM-project. Breast Cancer Res Treat 1995; 34: 55–61.
Ursin, G, Longnecker, MP, Haile, RW, Greenland, S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995; 6: 137–41.
Byers, T. Nutritional risk factors for breast cancer. Cancer 1994; 74: 288–95.
Howe, GR, Hirohata, T, Bishop, TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. JNCI 1990; 82: 561–9.
Boyd, NF, Noffel, MM, Lockwood, GA, Tritchler, DL. A meta-analysis of dietary fat and breast cancer risk. Br J Cancer 1993; 68: 627–36.
MacKenzie, I. The production of mammary cancer in rats using oestrogens. Br J Cancer 1955; 9: 284–99.
Staszewski, J. Age at menarche and breast cancer. JNCI 1971; 47: 935–40.
Trichopoulus, D, MacMahon, B, Cole, P. Menopause and breast cancer risk. JNCI 1972; 48: 605–13.
Clemmesen, J. Statistical Studies in Malignant Neoplasms. Volume 1. Copenhagen, Denmark: Munksgaard, 1965.
Lilienfeld, AM. The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 1956; 9: 927–34.
Zumoff, B. Hormonal profiles in women with breast cancer. Anticancer Res 1988; 8: 627–36.
Siiteri, PK, Hammond, GL, Nisker, JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike, MC, Siiteri, PK, Welsch, CW, eds. Hormones and Breast Cancer. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory, 1981; Banbury Report No. 8: 87–106.
Pardridge, WM. Serum availability of sex steroid hormones. Clin Endocrinol Metab 1986; 15: 259–78.
Mendel, CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10: 232–74.
Key, TJA, Pike, MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29–43.
Bernstein, L, Ross, RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15: 48–65.
Toniolo, PG, Levitz, M, Zeleniuch-Jacquotte, A, et al., A prospective study of endogenous estrogens and breast cancer in postmenopausal women. JNCI 1995; 87: 190–7.
Dorgan, JF, Longcope, C, Stephenson, HE, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomark Prev 1996; 5: 533–9.
Grattarola, R. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynaecol 1973; 116: 324–8.
Grattarola, R, Secreto, G, Recchione, C, Castellini, W. Androgens and breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynaecol 1974; 118: 173–8.
Sommers, SC, Theloh, HA. Ovarian stromal hyperplasia in breast cancer. Arch Pathol 1952; 53: 160–7.
Sommers, SC. Endocrine abnormalities in women with breast cancer. Lab Invest 1955; 4: 160–74.
Adams, J, Polson, DW, Franks, S. Prevalence of polycystic ovaries in women with anovulation and idiopatic hisutism. Br Med J 1986; 293: 355–9.
Conway, GS, Honour, JW, Jacobs, HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine, and ultrasound features in 556 patients. Clin Endocrinol 1989; 30: 459–70.
Franks, S. Polycystic ovary syndrome: a changing perspective. Clinical Endocrinol 1989; 31: 87–120.
Secreto, G, Fariselli, G, Bandieramonte, G, Recchione, C, Dati, V, DiPietro, S. Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. Eur J Cancer Clin Oncol 1983; 19: 5–10.
Secreto, G, Toniolo, P, Berrino, F, et al. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res 1984; 44: 5902–5.
Secreto, G, Recchione, C, Fariselli, G, DiPietro, S. High testosterone and low progesterone levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res 1984; 44: 841–4.
Secreto, G, Toniolo, P, Pisani, P, et al. Androgens and breast cancer in premenopausal women. Cancer Res 1989; 49: 471–6.
Secreto, G, Recchione, C, Cavalleri, M, Miraglia, M, Dati, V. Circulating levels of testosterone, 17β-oestradiol, luteinizing hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 1983; 47: 269–75.
Secreto, G, Toniolo, P, Berrino, F, et al. Serum and urinary androgens and risk of breast in postmenopausal women. Cancer Res 1991; 51: 2572–6.
Malarkey, WB, Schroeder, LL, Stevens, VC, James, AG, Lanese, RR. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 1977; 37: 4655–9.
McFadyen, IJ, Forrest, APM, Prescott, RJ, et al. Circulating hormone levels in women with breast cancer. Lancet 1976; i: 1100–2.
Adami, HO, Johansson, EDB, Vegelius, J, Victor, A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Uppsala J Med Sci 1979; 84: 259–74.
Hill, P, Garbaczewski, L, Kasumi, F. Plasma testosterone and breast cancer. Eur J Cancer Clin Oncol 1985; 21: 1256–66.
Wysowski, DK, Comstock, GW, Helsing, KJ, Lau, HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125: 791–9.
Garland, CF, Friedlander, NJ, Barrett-Connor, E, Khaw, KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992; 135: 1220–30.
Berrino, F, Muti, P, Micheli, A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. JNCI 1996; 88: 291–6.
Evans, D, Hoffmann, RG, Kalkhoff, RK, Kissebah, AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolite aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304–10.
Seidell, JC, Cigolini, M, Deurenberg, P, Oosterlee, A, Doornbos, G. Fat distribution, androgens, and metabolism in nonobese women. Am J Clin Nutr 1989; 50: 269–73.
Seidell, JC, Cigolini, M, Charzewska, J, et al. Androgenicity in relation to body fat distribution and metabolism in 38-year old women — the European fat distribution study. J Clin Epidemiol 1990; 43: 21–34.
Krotkiewski, M, Seidell, JC, Björntorp, P. Glucose tolerance and hyperinsulinemia in obese women: role of adipose tissue distribution, muscle fiber characteristics and androgens. J Intern Med 1990; 228: 385–92.
Weaver, JU, Holly, JMP, Kopelman, PG, et al. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol 1990; 33: 415–22.
Kaye, SA, Folsom, AR, Soler, JT, Prineas, RJ, Potter, JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991; 20: 151–6.
Peiris, AN, Sothman, MS, Aiman, MS, Kissebah, AH. The relationship of insulin to sex hormone-binding globulin: role of adiposity. Fertil Steril 1989; 52: 69–72
Soler, JT, Folsom, AR, Kaye, SA, Prineas, RJ. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis 1989; 79: 21–7.
Haffner, SM, Dunn, JF, Katz, MS. Relationship of sex-hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992; 41: 278–84.
Preziosi, P, Barrett-Connor, E, Papoz, L, et al. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab 1993; 76: 283–7.
Anderson, DC. Sex-hormone-binding globulin. Clin Endocrinol 1974; 3: 69–96.
Rosner, W. The functions of corticosteroid-binding globulin and sex-hormone-binding globulin: recent advances. Endocr Rev 1990; 11: 80–91.
Reaven, GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
Peiris, AN, Sothman, MS, Hennes, MI, et al. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am J Clin Nutr 1989; 49: 758–64.
Kirschner, MA, Samojlik, E, Drejka, M, Szmal, E, Schneider, G, Ertel, N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 1990; 70: 473: 9.
Kissebah, AH, Vydelingum, N, Murray, et al. Relation of body fat to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–60.
Evans, DJ, Hoffman, RG, Kalkhoff, RK, Kissebah, AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33: 68–75.
Amemiya, T, Kawahara, R, Yoshino, M, Komori, K, Hirata, Y. Population study on the adipose tissue distribution in Japanese women born in 1948. Diabetes Res Clin Prac 1990; 10: S71–6.
Evans, DJ, Barth, JH, Burke, CW. Body fat topography in women with androgen excess. Int J Obes 1988; 12: 157–62.
Schriock, ED, Buffington, CK, Hubert, GD, et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988; 66: 1329–31.
Buffington, CK, Givens, JR, Kitabchi, AE. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes 1991; 40: 693–700.
Poretsky, L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991; 12: 3–13.
Kissebah, AH, Peiris, A, Evans, DJ. Mechanisms associating body fat distribution with the abnormal metabolic profile in obesity. Rec Adv Obes Res 1987; 5: 54–9.
Leibel, RL, Edens, NK, Fried, SK. Physiologic basis for the control of body fat distribution in humans. Annu Rev Nutr 1989; 9: 417–43.
Bouchard, C, Desprès, JP, Mauriège, P. Genetic and non-genetic determinants of regional fat distribution. Endocr Rev 1993; 14: 72–93.
Björntorp, P. Insulin resistance and physical exercise in obesity. In: Oomura, Y et al, eds. Progress in Obesity Research. Washington, DC: John Libbey & Company 1990: 259–68.
Björntorp, P. Fatty acids, hyperinsulinaemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994; 5: 166–74.
Hernandez, ER, Resnick, CE, Holtzclaw, D, Payne, DW, Adashi, EY. Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular and pharmacological hormonal actions. Endocrinology 1988; 122: 2034–43.
Adashi, EY, Resnick, CE, D'Ercole, AJ, Svoboda, ME, van Wyk, JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocrinol Rev 1985; 6: 400–20.
Poretsky, L, Kalin, MF. The gonadotropic function of insulin. Endocrinol Rev 1987; 8: 132–41.
Nestler, JE, Strauss, JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991; 20: 807–23.
Kiddy, DS, Hamilton-Fairley, D, Seppälä, M, et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol 1989; 31: 757–63.
von Schoultz, B, Carlström, K. On the regulation of sexhormone-binding globulin — a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 1989; 2: 327–34.
Toscano, V, Balducci, P, Bianchi, P, Mangiantini, A, Sciarra, F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Mol Biol 1992; 43: 431–7.
Plymate, SR, Matej, LA, Jones, RE, Friedl, KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67: 460–4.
Plymate, SR, Hoop, RC, Jones, RE, Matej, LA. Regulation of sex hormone-binding globulin production by growth factors. Metabolism 1990; 39: 967–70.
Singh, A, Hamilton-Fairley, D, Koistinen, R, et al. Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex-hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 1990; 124: R1–3.
Holte, J, Bergh, T, Gennarelli, G, Wide, L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994; 41: 473–81.
Rajkhowa, M, Bicknell, J, Jones, M, Clayton, RN. Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril 1994; 61: 605–12.
Robinson, S, Kiddy, D, Gelding, SV, et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351–5.
Franks, S, Kiddy, DS, Hamilton-Fairley, D, Bush, A, Sharp, PS, Reed, MJ. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J Steroid Biochem Mol Biol 1991; 39: 835–8.
Sharp, PS, Kiddy, DS, Reed, MJ, Anyaoku, V, Johnston, DG, Franks, S. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol 1991; 35: 253–7.
Van den Brande, JL. Structure of the human insulin-like growth factors: relationship to function. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 12–44.
Holly, JMP, Wass, JAH. Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989; 122: 611–8.
Clemmons, DR. Structural and functional analysis of insulin-like growth factors. Br Med Bull 1989; 45: 465–80.
Humbel, RE. Insulin-like growth factors I and II. Eur J Biochem 1990; 190: 445–62.
Bang, P, Hall, K. Insulin-like growth factors as endocrine and paracrine hormones. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 151–77.
Moxham, C, Jacobs, S. Insulin-like growth factor receptors. In: Schofield PN. The Insulin-like Growth Factors; Structure and Biological Functions. Oxford, UK: Oxford University Press, 1992: 80–109.
Kahn, CR, White, MF. The insulin receptor and molecular mechanisms of insulin action. J Clin Invest 1988; 82: 1151–6.
D'Ercole, AJ, Stiles, AD, Underwood, LE. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984; 81: 935–9.
Cara, JF, Rosenfield, RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988; 123: 733–9.
Baxter, RC, Martin, JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49–68.
Clemmons, DR, Underwood, LE. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 1991; 11: 393–412.
Isley, WL, Underwood, LE, Clemmons, DR. Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. J Parenteral Enteral Nutr 1984; 8: 407–11.
Straus, DS. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J 1994; 8: 6–12.
Clemmons, DR, Klibanski, A, Underwood, LE, et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 1247–50.
Minuto, F, Barreca, A, Adami, GF, et al. Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. J Parenteral Enteral Nutr 1989; 13: 392–6.
Smith, AT, Clemmons, DR, Underwood, LE, Ben-Ezra, V, McMurray, R. The effect of exercise on plasma somatomedin-C/insulin-like growth factor I concentrations. Metabolism 1987; 36: 533–7.
Baxter, RC, Cowell, CT. Diurnal rhythm of the growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 1987; 65: 432–40.
Conover, CA, Lee, PD, Kanaley, JA, Clarkson, JT, Jensen, MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355–60.
Holly, JM, Biddlecombe, RA, Dunger, DB, et al. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol Oxf 1988; 29: 667–75.
Brismar, K, Gutniak, M, Povoa, G, Werner, S, Hall, K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988; 11: 599–602.
Brismar, K, Grill, V, Efendic, S, Hall, K. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism 1991; 40: 728–32.
Pekonen, F, Laatikainen, T, Buyalos, R, Rutanen, EM. Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease. Fertil Steril 1989; 51: 972–5.
Holly, JM, Eden, JA, Alaghband-Zadeh, J, et al. Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polcystic and multicystic ovaries. Clin Endocrinol Oxf 1990; 33: 53–64.
Suikkari, AM, Koivisto, VA, Rutanen, EM, Yki-Järvinen, H, Karonen, SL, Seppälä, M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988; 66: 266–72.
Cotterill, AM, Cowell, CT, Silink, M. Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2. J Endocrinol 1989; 123: R17–20.
Conover, CA, Lee, PD. Insulin regulation of insulin-like growth factor-binding protein production in cultured Hep G2 cells. J Clin Endocrinol Metab 1990; 70: 1062–7.
Powell, DR, Suwanichkul, A, Cubbage, ML, DePaolis, LA, Snuggs, MB, Lee, PDK. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18868–76.
bar, RS, Boes, M, Clemmons, D, et al. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in rat heart. Endocrinology 1990; 127: 497–9.
Adashi, EY, Resnick, CE, Hurwitz, A, et al. Insulin-like growth factors: the ovarian connection. Hum Reprod 1991; 6: 1213–9.
Koistinen, R, Suikkari, AM, Tiitinen, A, Kontula, K, Seppälä, M. Human granulosa cells contain insulin-like growth factor binding protein (IGFBP-1) mRNA. Clin Endocrinol Oxf 1990; 32: 635–40.
Yen, SSC. Chronic anovulation caused by peripheral endocrine disorders. In: Yen, SCC, Jaffe, RB, eds. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Philadelphia, PA (USA): Saunders Company, 1991: 576–629.
Moller, DE, Flier, JS. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991; 26: 938–48.
Dunaif, A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Medicine 1995; 98(Suppl 1A): 33S-39S.
Zavaroni, I, Bonara, E, Pagliara, M, et al. Risk factors for coronary artery disease in healthy persons with hyper-insulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702–6.
Ferranini, E, Buzzigoli, G, Bonadonna, R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7.
Beatty, OL, Harper, B, Sheridan, B, Atkinson, AB, Bell, PM, Insulin resistance in offspring of hypertensive parents. Br Med J 1993; 307: 92–6.
Allemann, Y, Horber, FF, Colombo, M, et al. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 1993; 341: 327–31.
Hollenbeck, C, Reaven, GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169–73.
Randle, PJ, Garland, PB, Hales, CN, Newsholme, EA. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785–9.
Clark, MG, Rattigan, S, Clark, DG. Obesity with insulin resistance: experimental results. Lancet 1983; ii: 1236–40.
DeFronzo, RA. The triumvirate: β-cell, muscle, liver-a collusion responsible for NIDDM. Diabetes 1988; 37: 667–87.
O'Dea, K. Westernization, insulin resistance and diabetes in Australian Aborigines. Med J Aust 1991: 155: 258–64.
Taylor, SI, Mukherjee, C, Jungas, RL. Studies on the mechanism of activation of adipose tissue pyruvate dehydrogenase by insulin. J Biol Chem 1973; 248: 73–81.
Taylor, SI, Mukherjee, C, Jungas, RL. Regulation of pyruvate dehydrogenase in isolated rat liver mitochondria. J Biol Chem 1975; 250: 2028–35.
Jeanrenaud, B, Halimi, S, van de Werve, G. Neuro-endocrine disorders seen as triggers of the triad: obesity-insulin resistance-abnormal glucose tolerance. Diabetes Metab Rev 1985; 1: 261–92.
Wititsuwannakul, D, Kim, K. Mechanism of palmityl coenzyme A inhibition on liver glycogen synthase. J Biol Chem 1977; 252: 7812–7.
Ebeling, P, Koivisto, VA. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 1994; 37: 202–9.
Lillioja, S, Mott, DM, Zawadzki, JK, Young, AA, Abbott, WG, Bogardus, C. Glucose storage is a major determinant of in vivo ‘insulin resistance’ in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986; 62: 922–7.
Shulman, GI, Rothman, DL, Jue, T, Stein, P, DeFronzo, RA, Shulman, RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Eng J Med 1990; 322: 223–8.
Kraegen, EW, Clark, PW, Jenkins, AB, Dalley, EA, Chilholm, DJ, Storlien, LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397–403.
Kiens, B, Essen-Gustavsson, B, Gad, P, Lithell, H. Lipoprotein lipase activity and intramuscular triglyceride stores after long-term high-fat and high-carbohydrate diets in physically trained men. Clin Physiol 1987; 7: 1–9.
Björntorp, P. Metabolic abnormalities in visceral obesity. Ann Med 1992; 24: 3–5.
Lonnqvist, F, Thome, A, Nilsell, K, Hoffstedt, J, Arner, P. A pathogenic role of visceral fat beta 3-adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109–16.
Mårin, P, Andersson, B, Ottoson, M, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 1992; 41: 1242–8.
Ferranini, E, Barrett, EJ, Bevilacqua, S. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737–47.
Golay, A, Swislocki, ALM, Chen, YDI, Reaven, GM. Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 1987; 7: 692–6.
Williamson, JR, Kreisberg, RA, Felts, PW. Mechanism for the stimulation of gluconeogenesis in perfused rat liver. Proc Natl Acad Sci USA 1966; 56: 247–54.
Williamson, JR, Browning, ET, Olson, M. Interrelations between fatty acid oxidation and the control of gluconeogenesis in perfused rat liver. Adv Enzyme Regul 1968; 6: 67–100.
Bar, RS, Harrison, LC, Muggeo, M, Gorden, P, Kahn, CR, Roth, J. Regulation of insulin receptors in normal and abnormal physiology in humants. Adv Intern Med 1972; 24: 23–52.
Gavin, JR, Roth, J, Neville, DM, de Meyts, P, Buell, DN. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci USA 1974; 7: 84–8.
Flier, JS. Insulin receptors and insulin resistance. Annu Rev Med 1983; 34: 145–60.
Kahn, CR. Role of insulin receptors in insulin resistant states. Metabolism 1980; 29: 455–66.
Fried, SK, Russell, CD, Grauso, NL, Brolin, RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92: 2191–8.
Ravussin, E, Swinburn, BA. Pathophysiology of obesity. Lancet 1992; 340: 404–8.
Wing, RR, Matthews, KA, Kuller, LH, et al. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. JAMA 1992; 268: 1890–5.
Ravussin, E, Valencia, ME, Esparza, J, Bennett, PH, Schulz, LO. Effects of a traditional lifestyle on obesity in Pima indians. Diabetes Care 1994; 17: 1067–74.
Flatt, JP. Dietary fat, carbohydrate balance, and weight maintenance. In: Klimeš, I, Howard, BV, Storlien, LH, Šebökovà, E, eds. Dietary Lipids and Insulin Action. New York, NY (USA): New York Acad Sci 1993: 122–40.
Swinburn, B, Ravussin, E. Energy balance or fat balance? Am J Clin Nutr 1993; 57 (Suppl): 766S-71S.
Astrup, A, Raben, A. Obesity: an inherited metabolic deficiency in the control of macronutrient balance? Eur J Clin Nutr 1992; 46: 611–20.
Westerterp, KR. Food quotient, respiratory quotient, and energy balance. Am J Clin Nutr 1993; 57(Suppl): 759S-65S.
Flatt, JP, Ravussin, E, Acheson, KJ, Jéquier, E. Effects of dietary fat on postprandrial substrate oxidation and on carbohydrate and fat balance. J Clin Invest 1985; 76: 1019–24.
Schutz, Y, Flatt, JP, Jéquier, E. Failure of fat to promote fat oxidation: a factor favoring the development of obesity. Am J Clin Nutr 1989; 50: 307–14.
Eckel, RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992; 340: 1452–3.
Astrup, A, Buemann, B, Western, P, Toubro, S, Raben, A, Christensen, NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 1994; 59: 350–5.
Hales, CN, Randle, PJ. Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acid, and insulin during oral glucose-tolerance tests. Lancet 1963; i: 790–4.
Fukagawa, NK, Anderson, JW, Hageman, G, Young, VR, Minaker, KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990; 52: 524–28.
Howard, BV, Abbott, WGH, Swinburn, BA. Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diabetes Care 1991; 14: 786–95.
Chen, M, Bergman, RN, Porte, D. Insulin resistance and β-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988; 67: 951–7.
Kolterman, OG, Greenfield, M, Reaven, GM, Saekow, M, Olefsky, JM. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 1979; 28: 731–6.
Beck-Nielsen, H, Pedersen, O, Sörensen, NS. Effects of diet on the cellular binding and the insulin sensitivity in young healthy subjects. Diabetologia 1978; 15: 289–96.
Grey, N, Kipnis, DM. Effect of diet composition on the hyperinsulinemia of obesity. N Engl J Med 1979: 285: 827–31.
Coulston, AM, Liu, GC, Reaven, RM. Plasma glucose, insulin and lipid responses to high-carbohydrate low-fat diets in normal humans. Metabolism 1983; 32: 52–6.
Danforth, E. Diet and obesity. Am J Clin Nutr 1985; 41: 1132–45.
Tucker, LA, Kano, MJ. Dietary fat and body fat: a multivariate study of 205 adult females. Am J Clin Nutr 1992; 56: 616–22.
Miller, WC, Lindeman, AK, Wallace, J, Niederpruem, M. Diet composition, energy intake, and exercise in relation to body fat in men and women. Am J Clin Nutr 1990; 52: 426–30.
Dreon, DM, Frey-Hewitt, B, Ellsworth, N, Williams, PT, Terry, RB, Wood, PD. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988; 47: 995–1000.
Romieu, I, Willett, WC, Stampfer, MJ, et al. Energy intake and other determinants of relative weight. Am J Clin Nutr 1988; 47: 406–12.
Lilienthal Heitman, B, Lissner, L, Sörensen, TIA, Bengtsson, C. Dietary fat and weight gain in women genetically predisposed for obesity. Am J Clin Nutr 1995; 61: 1213–7.
Gazzaniga, JM, Burns, TL. Relationship between diet composition and body fatness, with adjustment for resting energy expenditure and physical activity, in preadolescent children. Am J Clin Nutr 1993; 58: 21–8.
Parker, DR, Weiss, ST, Troisi, R, Cassano, PA, Vokonas, PS, Landsberg, L. Relationship of dietary fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr 1993; 58: 129–36.
Mayer, EJ, Newman, B, Quesenberry, CP, Selby, JV. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 1991; 16: 1459–69.
Maron, DJ, Fair, JM, Haskell, WL, et al. Saturated fat intake and insulin resistance in men with coronary heart disease. Circulation 1991; 84: 2020–7.
Lovejoy, J, DiGirolamo, M. Habitual dietary intake and insulin sensitivity in lean and obese adults. Am J Clin Nutr 1992; 55: 1174–9.
Feskens, EJM, Kromhout, D. Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen study. Int J Epidemiol 1990; 19: 953–59.
Marshall, JA, Hamman, RF, Baxter, J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol 1991; 134: 590–603.
Tsunehara, CH, Leonetti, DL, Fujimoto, WY. Diet of secondgeneration Japanese-American men with and without noninsulin-dependent diabetes. Am J Clin Nutr 1990; 52: 731–8.
Field, CJ, Ryan, EA, Thompson, ABR, Clandinin, MT. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 1990; 19: 11143–50.
Storlien, LH, Kraegen, EW, Chishol, DJ, Ford, GL, Bruce, DG, Pascoe, WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885–8.
Hainault, I, Carlotti, M, Hajduch, E, Guichard, C, Lavau, M. Fish oil in a high-lard diet prevents obesity, hyperlipemia, and adiposcyte insulin resistance in rats. Ann NY Acad Sci 1993; 683: 98–101.
Pelikanova, T, Kohout, M, Valek, J, Base, J, Kazdova, L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38: 188–92.
Borkman, M, Storlien, LH, Pan, DA, Jenkins, AB, Chisholm, DJ, Campbell, LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238–44.
Ruiz-Gutierrez, V, Stifel, P, Villar, J, Garcia-Donas, MA, Acosta, D, Carneado, J. Cell membrane fatty acid composition type 1 (insulin-dependent) diabetic patients: relationship with sodium transport abnormalities and metabolic control. Diabetologia 1993; 36: 850–6.
Agostoni, C, Riva, E, Bellu, R, Vicenzo, SS, Grazia, BM, Giovannini, M. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 317–21.
Feskens, EJM, Loeber, JG, Kromhout, D. Diet and physical activity as determinants of hyperinsulinaemia: the Zutphen elderly study. Am J Epidemiol 1994; 140: 350–60.
Trevisan, M, Krogh, V, Freudenheim, J, et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. JAMA 1990; 263: 688–92.
Popp-Snijders, C, Schouten, JA, Heine, RJ, van der Meer, J, ven der Veen, EA. Dietary supplementation of omega 3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin dependent diabetes. Diabetes Res 1987; 4: 141–7.
Schectman, G, Kaul, S, Kissebah, AH. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 1988; 37: 1567–73.
Pilch, PF, Thompson, PA, Czech, MP. Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulintreated adipocytes. Proc Natl Acad Sci USA 1980; 77: 915–8.
Ginsberg BH, Jabour J, Spector AA. Increased membrane fluidity is associated with greater sensitivity to insulin (Abstract). Diabetes 1987; 36(Suppl 1): 51A.
Truswell, AS. Glycaemic index of foods. Eur J Clin Nutr 1992; 46(Suppl 2): S91–101.
Jenkins, DA, Wolever, TMS, Taylor, RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362–6.
Collings, P, Williams, C, Macdonald, I. Effects of cooking on serum glucose and insulin responses to starch. Br Med J 1981; 282: 1032–3.
Brand, JC, Nicholson, PL, Thorburn, AW, Truswell, AS. Food processing and the glycemic index. Am J Clin Nutr 1985; 42: 1192–6.
Crapo, PA. Simple versus complex carbohydrate use in the diabetic diet. Annu Rev Nutr 1985; 5: 95–114.
Wolever, TMS. The glycemic index. In: Bourne, GH ed. Aspects of Some Vitamins, Minerals and Enzymes in Health and Disease. World Rev Nutr Diet (Basel, Karger) 1990; 62: 120–85.
Jenkins, DJA, Wolever, TMS, Jenkins, AL, Lee, R, Wong, GS, et al. Glycemic response to wheat products: reduced response to pasta but no effects of fiber. Diabetes Care 1983; 6: 155–90.
O'Dea, K, Nestel, PJ, Antonoff, L. Physical factors influencing postprandrial glucose and insulin responses to starch. Am J Clin Nutr 1980; 33: 760–5.
Jenkins, DJA, Wesson, V, Wolever, TMS, et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. Br Med J 1988; 297: 958–60.
Manolio, TA, Savage, PJ, Burke, GL, et al. Correlates of fasting insulin levels in young adults: the CARDIA study. J Clin Epidemiol 1991; 44: 571–8.
Feskens, EJ, Kromhout, D. Habitual dietary intake and glucose tolerance in euglycemic men: the Zutphen study. Int J Epidemiol 1990; 19: 953–9.
Marshall, JA, Weiss, NS, Hamman, RF. The role of dietary fibre in the etiology of non-insulin-dependent diabetes mellitus. Ann Epidemiol 1993; 3: 18–26.
Harlan, LC, Harlan, WR, Landis, JR, Goldstein, NG. Factors associated with glucose tolerance in US adults. Am J Epidemiol 1987; 126: 674–84.
Hill, JO, Prentice, AM. Sugar and body weight regulation. Am J Clin Nutr 1995; 62(Suppl): 264S-74S.
Koivisto, VA, Yki-Jarvinen, H, DeFronzo, RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1988; 1: 445–81.
Regensteiner, JG, Mayer, EJ, Shetterly, SM, et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. Diabetes Care 1991; 14: 1066–74.
Dowse, GK, Zimmet, PZ, Gareeboo, H, et al. Abdominal obesity and physical inactivity are risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 271–82.
Lindgarde, F, Saltin, B, Daily physical activity, work capacity and glucose tolerance in lean and obese normo-glycaemic middle-aged men. Diabetologia 1981; 20: 137–8.
Wang, JT, Ho, LT, Tang, KT, Wang, LM, Chen, YDI, Reaven, GM. Effect of habitual physical activity on age-related glucose intolerance. J Am Geriatr Soc 1989; 37: 203–9.
Manson, JE, Rimm, E, Stampfer, MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991; 338: 774–8.
Holly, JMP, Smith, CP, Dunger, DB, et al. Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development? Clin Endocrinol 1989; 31: 277–84.
Belgorosky, A, Rivarola, MA. Progressive increase in nonsex hormone-binding-globulin-bound testosterone and estradiol from infancy to late puberty in girls. J Clin Endocrinol Metab 1988; 67: 234–7.
Bartsch, W, Horst, HJ, Derwahl, KM. Interrelations between sex-hormone-binding globulin and 17β-estradiol, testosterone, 5(-dihydroxytestosterone, thyroxine, and triiodothyronine in prepubertal and pubertal girls. J Clin Endocrinol Metab 1980; 50: 1053–6.
Apter, D, Vihko, R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1984; 71: 970–4.
Apter, D, Bolton, NJ, Hammond, GL, Vihko, R. Serum sex hormone binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinologica 1984; 107: 413–9.
Lee, IR, Lawder, LE, Townend, DC, Wetherall, JD, Hahnel, R. Plasma sex hormone binding globulin concentrations and binding capacity in children before and during puberty. Acta Endocrinologica 1985; 109: 276–80.
Holly, JMP, Smith, CP, Dunger, DB, et al. Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 1989; 121: 383–7.
Argente, J, Barrios, V, Pozo, J, et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 1993; 77: 1522–8.
Lautala, P, Åkerblom, HK, Viikari, J, et al. Atherosclerosis precursors in Finnish children and adolescents. VII. Serum immunoreactive insulin. Acta Paediatr Scand 1985; 318(Suppl): 127–33.
Amiel, SA, Sherwin, RS, Simonson, DC, Lauritano, AA, Tamborlane, WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215–9.
Bloch, CA, Clemons, P, Sperling, MA. Puberty decreases insulin sensitivity. J Pediatr 1987; 110: 481–7.
Caprio, S, Plewe, G, Diamond, MD, et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989; 114: 963–7.
Smith, CP, Archibald, HR, Thomas, JM, et al. Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol 1988; 28: 7–14.
Laron, Z, Aurbach-Klipper, Y, Flasterstein, B, Litwin, A, Dickerman, Z, Heding, LG. Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. Clin Endocrinol 1988; 29: 625–32.
Travers, SH, Jeffers, BW, Bloch, CA, Hill, JO, Eckel, RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995; 80: 172–8.
Clemmons, DR, van Wyk, JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984; 13: 113–43.
Smith, CP, Dunger, DB, Williams, AJK, et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 1989; 68: 932–7.
Hesse, V, Jahreis, G, Schmabach, H, et al. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp Clin Endocrinol 1994; 102: 289–8.
Wilson, DW, Killen, JD, Hammer, LD, et al. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls. J Clin Endocrinol Metab 1991; 73: 907–12.
Copeland, KC, Colletti, RB, Devlin, JT, McAuliffe, TL. The relationship between insulin-like growth factor I, adiposity, and aging. Metabolism 1990; 39: 584–7.
Hindmarsh, P, Di Silvio, PJ, Pringle, PJ, Kurtz, AB, Brook, CGD. Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clin Endocrinol 1988; 28: 381–8.
Arslanian, SA, Kalhan, SC. Correlations between fatty acid and glucose metabolism: potential explanation of insulin resitance during puberty. Diabetes 1994; 43: 908–14.
Benassi, L, Tridenti, G, Orlandi, N, Pezzarossa, A. Glucose tolerance and insulin release in adolescent female. J Endocrinol Invest 1991; 14: 751–6.
Rosenfeld, RG, Wilson, DM, Dollar, LA, Bennett, A, Hintz, RL. Both pituitary growth hormone and recombinant DNA-derived growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 1992; 54: 1033–8.
Press, M, Tamborlane, WV, Sherwin, RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 1984; 310: 810–5.
Rizza, RA, Mandarino, LJ, Gerich, JE. Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982; 31: 663–9.
Martha, PM, Reiter, EO. Pubertal growth and growth hormone secretion. Endocrinol Metab Clin North Am 1991; 20: 165–82.
Bratusch-Marrain, PR, Smith, D, DeFronzo, RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982; 55: 973–82.
Zwiauer, KF, Pakosta, R, Mueller, T, Widhalm, K. Cardiovascular risk factors in obese children in relation to weight and body fat distribution. J Am Coll Nutr 1992; 11(Suppl): 41S-50S.
Kikuchi, DA, Srinivasan, SR, Harsha, DW, Webber, LS, Sellers, TA, Berenson, GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev Med 1992; 21: 177–90.
Hoffman, RP, Stumbo, PJ, Janz, KF, Nielsen, DH. Altered insulin resistance is associated with increased dietary weight loss in obese children. Horm Res 1995;44: 17–22.
Wabitsch, M, Hauner, H, Heinze, E, et al. Body fat distribution and changes in the atherogenic risk-factor profile in obese adolescent girls during weight reduction. Am J Clin Nutr 1994; 60: 54–60.
Arslanian, S, Suprasongsin, C. Insulin sensitivity, lipids, and body composition in childhood: is ‘syndrome X’ present? J Clin Endocrinol Metab 1996; 81: 1058–62.
Klesges, RC, Klesges, LM, Eck, LH, Shelton, ML. A longitudinal analysis of accelerated weight gain in preschool children. Pediatrics 1995; 95: 126–30.
Esposito del Puente, A, Scalfi, L, de Filippo, E, et al. Familial and environmental influences on body composition and body fat distribution in childhood in southern Italy. Int J Obes Relat Metab Disord 1994; 18: 596–601.
Pasquali, R, Casimirri, F, Venturoli, S, et al. Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism 1994; 43: 706–13.
Rebuffe-Scrive, M, Cullberg, G, Lundberg, PA, Lindstedt, G, Bjorntorp, P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res 1989; 21: 391–7.
Bringer, J, Lefebvre, P, Boulet, F, et al. Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann N Y Acad Sci 1993; 687: 115–23.
Lanzone, A, Fulghese, AM, Pappalardo, S, et al. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Gynecol Obstet Invest 1990; 29: 149–53.
Chang, RJ, Nakamura, RM, Judd, HL, Kaplan, SO. J Clin Endocrinol Metab 1983; 57: 356–9.
Rittmaster, RS, Deshwal, N, Lehman, L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J Clin Endocrinol Metab 1993; 76: 1295–1300.
Conway, GS, Jacobs, HS, Holly, JMP, Wass, JAS. Effects of luteinizing hormone, insulin, insulin-like growth factor I and insulin-like growth factor small binding protein in the polycystic ovary syndrome. Clin Endocrinol 1990; 33: 593–603.
Tropeano, G, Licisano, A, Liberale, I, et al. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1994; 78: 305–9.
Dunaif, A, Graf, M, Mandeli, J, Laumas, V, Dobrjanski, A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65: 499–507.
Dunaif, A, Segal, KR, Futterweit, W, Dobrjansky, A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–74.
Suikkari, AM, Ruutiainen, K, Erkkola, R, Seppälä, M. Low levels of low molecular weight insulin-like growth factor binding protein in patients with polycystic ovarian disease. Hum Reprod 1989; 4: 136–9.
Franks, S, Kiddy, D, Sharp, P, et al. Obesity and polycystic ovary syndrome. Ann NY Acad Sci 1991; 626: 201–6.
Kiddy, DS, Hamilton-Fairley, D, Bush, A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105–11.
Venturoli, S, Porcu, E, Fabbri, R, et al. Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology. Hormone Res 1986; 24: 269–79.
Polson, DW, Wadsworth, J, Adams, J, Franks, S. Polycystic ovaries — a common finding in normal women. Lancet 1988; i: 870–2.
Clayton, RN, Ogden, V, Hodgkinson, J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992; 37: 127–34.
Abdel-Gadir, A, Khatim, MS, Mowafi, RS, Alnaser, HM, Muharib, NS, Shaw, RW. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992; 7: 453–7.
Nobels, F, Dewailly, D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 1992; 58: 655–66.
Lucky, AW, Rosenfield, RL, McGuire, J, Rudy, S, Helke, J. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: Adreanl enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 1986; 62: 840–8.
Ehrmann, DA, Barnes, RB, Rosenfield, RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322–53.
Pasquali, R, Casimirri, F. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res 1993; 39: 179–87.
Barbieri, RL, Smith, S, Ryan, KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988; 50: 197–212.
Rosenfield, RL, Barnes, RB, Cara, JF, Lucky, AW. Dysregulation of cytochrome P450c17 (as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785–91.
Magoffin, DA, Kurtz, KM, Erickson, GF. Insulin-like growth factor selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells. Mol Endocrinol 1990; 4: 489–96.
Magoffin, DA, Weitsman, SR. Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I. Endocrinology 1993; 132: 1945–51.
Hiney, JK, Ojeda, SR, Dees, WL. Insulin-like growth factor I: a possible metabolic signal involved in the regulation of female puberty. Neuroendocrinology 1991; 54: 420–3.
Kazer, R. The etiology of polycystic ovary syndrome (PCO). Med Hypotheses 1992; 30: 151–5.
Venturoli, S, Porcu, E, Fabbri, R, et al. Postmenarcheal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril 1987; 48: 78–85.
Apter, D, Vihko, R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Endocrinol Metab 1990; 71: 970–4.
Simpson, JL. Elucidating the genetics of polycystic ovary syndrome. In: Dunaif, A, Givens, JR, Haseltine, FP, Merriam, GR, eds. Polycystic Ovary Syndrome. Oxford, UK: Black-well Scientific Publications, 1992: Chapter 6: 59–69.
Carey, AH, Chan, KL, Short, F, White, D, Williams, R, Franks, S. Evidence for a single gene effect causing polycystic ovary syndrome and male pattern baldness. Clin Endocrinol 1992; 38: 653–8.
Carey, AH, Waterworth, D, Patel, K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873–6.
Dunaif, A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995; 98: 1A-33S.
Prelevic, GM, Wurzburger, MI, Balint-Peric, I, Ginsburg, J. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 1992; 37: 125–31.
Kazer, RR, Unterman, TG, Glick, RP. An abnormality of the growth hormone/insulin-like growth factor axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1990; 71: 958–62.
Insler, V, Shoham, Z, Barash, A, et al. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod 1993; 8: 379–84.
Insler, V, Barash, A, Shoham, Z, et al. Overnight secretion pattern of growth hormone, sex hormone-binding globulin, insulin-like growth factor I, and its binding protein in obese and non-obese women with polycystic ovarian disease. Isr J Med Sci 1994; 30: 42–7.
Kopelman, PG, White, N, Pilkington, TR, Jeffcoate, SL. The effect of weight loss on sex steroid secretion and binding in massively obese women. Clin Endocrinol Oxf 1981; 15: 113–6.
Bates, GW, Whitworth, NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 1982; 38: 406–9.
Harlass, FE, Plymate, SR, Fariss, BL, Belts, RP. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 1984; 42: 649–52.
Crave, JC, Fimbel, S, Lejeune, H, Cugnardey, N, Dechaud, H, Pugeat, M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995; 80: 2057–62.
Wabitsch, M, Hauner, H, Heinze, E, et al. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. J Clin Endocrinol Metab 1995; 80: 3469–75.
Cross, M, Dexter, TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271–80.
Baserga, R, Porcu, P, Sell, C. Oncogenes, growth factors and control of the cell cycle. Cancer Surv 1993; 16: 201–13.
King, RJB. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J Steroid Biochem Molec Biol 1991; 39: 811–8.
Shi, YE, Liu, YE, Lippman, ME, Dickson, RB. Progestins and antiprogestins in mammary tumour growth and metastasis. Hum Reprod 1994; 9: 162–73.
Henderson, BE, Ross, R, Bernstein, L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 1988; 48: 246–53.
Fernig, DG, Smith, JA, Rudland, PS. Relationship of growth factors and differentiation and neoplastic development of the mammary gland. In: Lippman, M, Dickson, R, eds. Regulatory Mechanisms in Breast Cancer. Boston, MA (USA): Kluwer Publishers, 1991: 47–78.
Henderson, BE, Ross, RK, Judd, HL, Krailo, MD, Pike, MC. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985; 56: 1206–8.
Spicer, DV, Pike, MC. The prevention of breast cancer through reduced ovarian steroid exposure. Acta Oncologica 1992; 31: 167–74.
Pike, MC, Spicer, DV, Dahmoush, L, Press, MF. Estrogens, progestagens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17–35.
Key, TJA, Pike, MC. The dose-effect relationship between ‘unopposed’ estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988; 57: 205–12.
Macaulay, VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311–20.
Yee, D, Rosen, N, Favoni, RE, Cullen, KJ. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. In: Lippman, Dickson, eds. Regulatory Mechanisms in Breast Cancer. Boston, MA (USA): Kluwer Publishers 1991: 93–105.
Hilf, R. The actions of insulin as a hormonal factor in breast cancer. In: Pike, MC, Siiteri, PK, Welsch, CW, eds. Hormones and Breast Cancer. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory, 1981; Banbury Report No. 8: 317–37.
Stoll, BA. Breast cancer: the obesity connection. Br J Cancer 1994; 69: 799–801.
Bruning, PF, Bonfrèr, JMG, van Noord, PAH, Hart, AAM, de Jong-Bakker, M, Nooijen, WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52: 511–6.
Adami, HO, Rimsten, A. Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls. Clin Oncol 1978; 4: 243–9.
Ragozzino, M, Melton, LJ, Chu, CP, Palumbo, PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chron Dis 1982; 35: 13–9.
O'Mara, BA, Byers, T, Schoenfeld, E. Diabetes mellitus and cancer risk: a multi-site case-control study. J Chron Dis 1985; 38: 435–41.
Franceschi, S, la Vecchia, C, Negri, E, Parazzini, F, Boyle, P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781–5.
Adami, HO, McLaughlin, J, Ekbom, A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307–14.
Moseson, M, Koenig, KL, Shore, RE, Pasternack, BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993; 22: 1000–9.
La Vecchia, C, Negri, E, Franceschi, S, D'Avanzo, B, Boyle, P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950–3.
Andersson, B, Marin, P, Lissner, L, Vermeulen, A, Bjorntorp, P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994; 17: 405–11.
Nyholm, H, Djursing, H, Hagen, C, Agner, T, Bennett, P, Svenstrup, B. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 1989; 69: 946–9.
Djursing, H, Hagen, C, Nyboe-Andersen, A, Sventrup, B, Bennet, P, Mølsted-Pedersen, L. Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhea. Clin Endocrinol 1985; 23: 147–54.
Prelevic, GM, Wurzburger, MI, Peric, LA. The effect of residual beta-cell activity on menstruation and the reproductive hormone profile of insulin-dependent diabetics. Arch Gynecol Obstet 1989; 244: 207–13.
Alexander, L, Appleton, D, Hall, R, Ross, WM, Wlikinson, R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol Oxf 1980; 12: 71–9.
Nabarro, JDN. Acromegaly. Clin Endocrinol Oxf 1987; 26: 481–512.
Bengtsson, BÅ, Edén, S, Ernest, I, Odén, A, Sjögren, B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988; 223: 327–35.
Ron, E, Gridley, G, Hrubec, Z, Page, W, Arora, S, Fraumeni, JFJr. Acromegaly and gastrointestinal cancer. Cancer 1991; 68: 1673–7.
Barzilay, J, Heatley, GJ, Cushing, GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991; 151: 1629–32.
Klein, I, Parveen, G, Gavaler, JS, Vanthiel, DH. Colonic polyps in patients with acromegaly. Ann Intern Med 1982; 97: 27–30.
Ituarte, EM, Petrini, J, Hershman, JM. Acromegaly and colon cancer. Ann Intern Med 1984; 101: 627–8.
Pines, A, Rozen, P, Ron, E, Gilat, T. Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 1985; 80: 266–9.
Ritter, MM, Richter, WO, Schwandt, P. Acromegaly and colon cancer. Ann Intern Med 1987; 106: 636–7.
Ziel, FH, Peters, AL. Acromegaly and gastrointestinal adenocarcinomas. Ann Intern Med 1988; 109: 514–5.
Brunner, JE, Johnson, CC, Zafar, S, Peterson, EL, Brunner, JF, Mellinger, RC. Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol Oxf 1990; 32: 65–71.
Ezzat, S, Strom, C, Melmed, S. Colon polyps in acromegaly. Ann Int Med 1991; 114: 754–5.
Wynder, EL, Hebert, JR. Homogeneity and nutritional exposure: an impediment in cancer epidemiology? JNCI 1987; 79: 605–7.
Giovannucci, E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164–79.
McKeown-Eyssen, G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 1994; 3: 687–95.
Siiteri, PK, MacDonald, PC. The role of extraglandular estrogen in human endocrinology. In: Geiger, SR, Astwood, EB, Geep, RO, eds. Handbook of Physiology. New York, NY (USA): American Physiological Society, 1973: 615–29.
Siiteri, PK. Obesity and peripheral estrogen synthesis. In: Frisch, RE, ed. Adipose Tissue and Reproduction. Basel, Switzerland: Karger 1990; Progr Reprod Biol Med: 14: 70–84.
Coulam, CB, Annegers, JF, Kranz, JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983; 61: 403–7.
Gammon, MD, Thompson, WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991; 134: 818–24.
Ibanez, L, Potau, N, Virdis, R, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599–603.
Lazar, L, Kauli, R, Bruchis, C, Nordenberg, J, Galatzer, A, Pertzelan, A. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol 1995; 133: 403–6.